Heart Failure with Nonischemic Cardiomyopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-08-07
Clinical Trial Update: Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL) [Phase 3]
Phase 3 clinical trial update evaluating ERTugliflozin for reducing cardiac fibrosis in Korean patients with nonischemic cardiomyopathy, usi…